Everything Lupus: Resource Hub
Government of Canada signs new COVID-19 antibody therapy agreement
Read
Canadian Rheumatology Association Position Statement on COVID-19 Vaccination
Read
Canadian Rheumatology Association Improves Outcomes In SLE
Read
Lupus Canada is pleased to share that Health Canada has approved Evusheld for pre-exposure prophylaxis of COVID-19 in immune-compromised individuals.
Read
GSK’s Belimumab shows significant improvement in renal function in the largest Lupus Nephritis (LN) clinical study
Read
Evusheld authorized by Health Canada
Read
AstraZeneca’s Anifrolumab demonstrated early and sustained reduction of disease activity in SLE patients in the Phase III Tulip clinical trial
Read
From Manchester to Toronto – Improving lupus ‘brain fog’
Read
Supporting the wellbeing of Canadians with lupus: evidence-informed advocacy
Read
Creating a clearer picture of lupus
Read
Determinants of Neuropsychiatric Flares in People with Lupus
Read
Immune-compromised Canadians and COVID-19 – Patient-Oriented Resources
Read
